KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer
Acta Biochimica et Biophysica Sinica · 01.02.2025
DOI: 10.3724/abbs.2025022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 24.02.2025. Verfasst von Anli Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus E7 Proteins, Histone Acetyltransferases, Papillomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Persistent human papillomavirus (HPV) infection serves as the principal etiological factor in cervical cancer, with the oncoprotein E7, which is encoded by the virus, playing a key role in tumorigenesis. However, targeted therapeutic strategies against E7 remain underexplored. KAT8, a lysine acetyltransferase, significantly contributes to oncogenesis through the regulation of transcription. However, its involvement in cervical cancer remains inadequately characterized. This study employs HPV18-positive HeLa and HPV16-positive SiHa cell lines to investigate how KAT8 modulates E7 expression and function in cervical cancer cells. Upon KAT8 knockdown, a marked reduction in cell viability is observed, alongside a decrease in E7 expression. This is associated with elevated level of retinoblastoma protein (pRb) and decreased E2F1 expression, indicating that KAT8 depletion inhibits E7 expression, resulting in E2F1 inactivation and cell cycle arrest. Furthermore, KAT8 directly binds to the promoter regions of the HPV18 LCR, enhancing the transcription of the HPV18 E7 gene. This study also demonstrates that KAT8 is essential for the acetylation of E7 and plays a critical role in facilitating the interaction between pRb/E2F1 and E7 in cervical cancer cells. In conclusion, these results highlight KAT8 as a key driver of cervical cancer progression, promoting the expression of HPV E7 and its associated oncogenic signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China.
- Department of Gynecology and Obstetrics, Yuhuangding Hospital, Yantai 264000, China.
- Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, Life Science School of Shandong University, Qingdao 266237, China.
- Shandong Key Laboratory of Reproductive Research and Birth Defect Prevention, Jinan 250021, China.
- Gynecology Laboratory, Shandong Provincial Hospital, Jinan 250021, China.
Zitieren
APA
Xu, A., Yang, X., Zhao, J., Kong, S., Tang, Q., Li, X., Qu, H., & Wang, G. (2025). KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025022
Vancouver
Xu A, Yang X, Zhao J, Kong S, Tang Q, Li X, et al. KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025022
BibTeX
@article{Xu2025,
author = {Xu, Anli and Yang, Xiaoming and Zhao, Junwei and Kong, Shujun and Tang, Qing and Li, Xiangzhi and Qu, Hongmei and Wang, Guoyun},
title = {KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
doi = {10.3724/abbs.2025022}
}
EUVIMED